HBV genes induce cytotoxic T-lymphocyte response upon adeno-associated virus (AAV) vector delivery into dendritic cells

Journal of Viral Hepatitis

Volumn 13, Issue 9, 2006, Pages 605-612

  You, H ^a,b   Liu, Y ^b   Cong, M ^a   Ping, W ^a   You, C ^b   Zhang, D ^b   Mehta, J L ^b   Hermonat, P L ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Adeno associated virus; Hepatitis B; Immunotherapy; Transduction

Indexed keywords

GAMMA INTERFERON; HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIGEN; PARVOVIRUS VECTOR;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EMBRYO; GENETIC TRANSDUCTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B VIRUS C GENE; HEPATITIS B VIRUS S GENE; HEPATITIS B VIRUS X GENE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; IN VITRO STUDY; INTERFERON PRODUCTION; LIVER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PRIORITY JOURNAL; TARGET CELL DESTRUCTION; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE; VIRUS RECOMBINANT;

ANTIGENS, CD; CELL LINE; CELLS, CULTURED; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRITIC CELLS; DEPENDOVIRUS; FLOW CYTOMETRY; GENES, VIRAL; GENETIC VECTORS; HEPATITIS B VIRUS; HUMANS; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC;

EID: 33747194373     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2006.00734.x     Document Type: Article

References (25)

1. Herrero E. Hepatitis B and hepatitis C co-infection in patients with HIV. Rev Med Virol 2001; 11: 253-270.
2. Malik AH, Lee WM. Chronic hepatitis B virus infection: treatment strategies for the next millennium. Anal Inter Med 2000; 132: 723-731.
3. Penna A, Chisari FV, Bertoletti A et al. Cyotoxic T lymphocytes recognize an HLA-A2 restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991; 174: 1565-1570.
4. Chisari FV, Ferrari C. Hepatits B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60.
5. Chisari FV. Cytotoxic T-cells and viral hepatitis. J Clin Invest 1997; 99: 1472-1477.
6. Beckebaum S, Cicinnati VR, Gerken G. DNA-based immunotherapy, potential for treatment of chronic viral hepatitis? Rev Med Virol 2002; 12: 297-319.
7. Steinman RA. The DC system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271-296.
8. Young JW, Inaba K. DCs as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J Exp Med 1996; 183: 7-11.
9. Sallusto F, Lanzavecchia A. Efficient presentation of soluable antigen by cultured human dendritic cells is maintanined by granulocyte/macrophage colony stimulating factor plus interleukin 4 and down regulated by tumor necrosis factor alpha. J Exp Med 1994; 17: 1109.
10. Santin AD, Hermonat PL, Ravaggi A et al. Kinetics of expression of surface antigens during the differentiation of human dendritic cells versus macrophages from monocytes in vitro. Immunobiology 1999; 200: 187-204.
11. Luft T, Pang KC, Thomas E et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 1998; 161: 1947-1953.
12. Chen BG, Shi YJ, Smith JD et al. The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4(+) T cells in vitro. Blood 1998; 91: 4652-4661.
13. Santin AD, Hermonat PL, Ravaggi A et al. Generation of an MHC class I restricted cytotoxic T cell response against autologous cervical cancer tumor cells by lipofection of synthetic human papillomavirus types 16 and 18 E7 protein into primary dendritic cells. J Virol 1999; 73: 5402-5410.
14. Jochmus I, Osen W, Altmann A et al. Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide. J Gen Virol 1997; 78: 1689-1695.
15. Sallberg M, Hughes J, Javadian A et al. Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen. Hum Gene Ther 1998; 9: 1719-1729.
16. Liu Y, Chiriva-Internati M, Grizzi F et al. Rapid induction of cytotoxic T cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector. Can Gene Therapy 2001; 8: 948-957.
17. Chiriva-Internati M, Liu Y, Salati E et al. Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus-human papillomavirus type 16 E7 antigen transduction into dendritic cells. Eur J Immunol 2002; 32: 30-38.
18. Chiriva-Internati M, Liu Y, Weidanz JA et al. Testing recombinant adenoassociated virus-based gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma. Blood 2003; 102: 3100-3107.
19. Collaco RF, Cao X, Trempe JP. A helper virus-free packaging system for recombinant adeno-associated virus vectors. Gene 1999; 238: 397-405.
20. Pala P, Verhoef A, Lamb JR et al. Single cell analysis of cytokine expression kinetics by human CD4+ T-cell clones during activation or tolerance induction. Immunology 2000; 100: 209-216.
21. You Z, Huang XF, Hester J et al. Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway. J Immunol 2000; 165: 4581-4591.
22. Beckebaum S, Cicinnati VR, Zhang X et al. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology 2003; 109: 487-495.
23. Shimizu Y, Guidotti LG, Fowler P et al. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol 1998; 161: 4520-4529.
24. Livingston BD, Crimi C, Grey H et al. The hepatitis B virus-specific CTL response induced in humans by lipopeptide vaccine are comparable to those elicited by acute viral infection. J Immunol 1997; 159: 1383-1392.
25. Heathcote J, McHutchison J, Lee S et al. T cell vaccine study group: a pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. Hepatology 1999; 30: 531-536.